{"id":"W3093018885","doi":"10.1016/j.eclinm.2020.100573","title":"Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: A systematic literature review and network meta-analysis","year":2020,"lang":"en","type":"article","venue":"EClinicalMedicine","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre for Advancing Health Outcomes; McMaster University; Impact; University of British Columbia","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; World Health Organization","keywords":"Dolutegravir; Efavirenz; Medicine; Emtricitabine; Tolerability; Adverse effect; Internal medicine; Population; Odds ratio; Discontinuation; Viral load; Virology; Antiretroviral therapy; Human immunodeficiency virus (HIV); Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000949699,0.0004522383,0.005783092,0.00008541149,0.0001318066,0.00002165668,0.00007171816,0.000130662,0.00006181623],"category_scores_gemma":[0.0004671722,0.0002451794,0.0006438353,0.0006778351,0.0004154233,0.0000771905,0.00005561475,0.0001867177,0.000001511494],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002930451,"about_ca_system_score_gemma":0.0000414628,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000730333,"about_ca_topic_score_gemma":0.00003175383,"domain_scores_codex":[0.9970431,0.0002811903,0.001492016,0.0006671023,0.0002556753,0.0002609337],"domain_scores_gemma":[0.9965136,0.002086514,0.0004870532,0.0003927901,0.0001592269,0.000360825],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.003922052,0.001704741,0.49155,0.1205523,0.3595381,0.0001281214,0.01688019,0.00002908236,0.00001464681,0.000383531,0.003637939,0.001659277],"study_design_scores_gemma":[0.01809411,0.006644696,0.1425377,0.01486871,0.8112605,0.00004515204,0.0004507474,0.003168768,0.0000249744,0.0001577171,0.002116898,0.0006301047],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.2065544,0.7396285,0.0006333693,0.04539841,0.00004376221,0.007305104,0.00025788,0.00007739195,0.0001011657],"genre_scores_gemma":[0.9345977,0.05957555,0.002786147,0.001359247,0.0001552414,0.0002404368,0.0003533789,0.00002275393,0.0009095515],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.7280433,"threshold_uncertainty_score":0.9998127,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09930021354409332,"score_gpt":0.3594091856381585,"score_spread":0.2601089720940652,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}